Virgínia MarecoCentro Hospitalar Lisboa Norte | HSM · Radiotherapy
Virgínia Mareco
MD
Radiation Oncologist, Physician.
About
40
Publications
2,825
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
16
Citations
Introduction
Medical doctor degree, by Faculdade de Medicina, Universidade de Lisboa (FMUL), Portugal. Radiation Oncology residence in Centro Hospitalar Universitário Lisboa Norte, EPE, where she is a specialist and residence mentor. Fellowship in Institut Gustave Roussy, France, and internship in AC Camargo Cancer Center, Brazil. Epidemiology postgraduation, FMUL. Editorial member and reviewer of medical journals. Author of papers and posters.
Additional affiliations
October 2015 - present
Centro Hospitalar Lisboa Norte, EPE
Position
- Radiation Oncologist
Education
October 2016 - July 2017
March 2016 - March 2016
Publications
Publications (40)
Introduction
Despite modern radiotherapy (RT) techniques, radiation-induced proctitis (RIP) remains a significant complication of RT for pelvic organ malignancies. Over the last decades, an enormous therapeutic armamentarium has been considered in RIP, including hyperbaric oxygen therapy (HBOT). However, the evidence regarding the impact of HBOT on...
p class="abstract">Merkel cell carcinoma is a rare neuroendocrine tumour of the skin, that shows a quickly and aggressive behaviour and carries a poor prognosis. Surgery is the standard primary treatment modality, while radiotherapy plays a role in postoperative treatment. Radiotherapy is also an alternative to unresectable lesions or patients who...
Portuguese Multidiscilinary Consensus on Advanced Prostate Cancer
To report the experience and the outcomes of interstitial high-dose-rate (HDR) brachytherapy (BT) of eyelid skin cancer at the Department of Radiotherapy of Hospital de Santa Maria in Lisbon.
Seventeen patients (pts; mean age, 73.75 years) who underwent eyelid interstitial HDR BT with an (192)Ir source between January 2011 and February 2013 were an...
Background: Neoadjuvant chemoradiotherapy (NCRT) followed by esophagectomy is the most common approach for patients (pts) with locally advanced esophageal cancer (EC). NCRT has the potential to downstage EC, increase complete resection (R0) and to induce a complete pathologic remission (cPR) which has been demonstrated to be a predictor of survival...
Background: Human immunodeficiency virus (HIV) infection has been associated with increased risk for development of lymphoproliferative disorders. The prevalence of HIV-related malignancies is expected to increase as HIV+ patients (pts) continue to live longer. Oral plasmablastic lymphoma (PBL) is not a frequent event among HIV+ individuals. Progno...
The publication is an abstract.
Questions
Questions (8)
Nós apenas fazemos uma margem para o GTVp ou podemos fazer uma magin para o GTVn? And do we contour all the lynph nodes areas such as in the long course of chemoradiation, ir just a Simple margin to GTV?
What is the date of the cancer diagnosis? It is the date of collection of the biopsy? Or is the date of the pathological anatomy report? Because this question has implications for survival time.
What is the real definition of radiosurgery (SRS)? Stereotactic radiotherapy (SRT) in the central nervous system, including the spinal cord, or SRT in a single fraction in any part of the body?
Is there any place for reirradiation of rectal cancer with hypofractionation (e.g., 5 x 5 Gy)? In a tumor that had resisted to conventional chemoradiation?
Is the risk of necrosis on the helix cartilage of the auricle high? With 50 Gy in 20 fractions and electrons?
Is there any benefit in irradiating a skin tumor that has necrosed after cetuximab and shows a solution of continuity with the subcutaneous cellular tissue, although it is still present (partial response) and it is associated with local lymphadenopathies? Will the wound ever heal?
In a patient with nodular Kaposi's sarcoma dispersed through the entire the lower limb and inguinal lymphadenopathy, do you agree to irradiate with photons the entire lower limb and inguinal area? There will be no major side effects? There are other options?
How to treat a nodular Kaposi's sarcoma of the lower limbs in an immunocompromised patient with ataxia-telangiectasia? With radiotherapy? What technique? What dose? What fractionation?
